#GossamerBio
LightNews LightNews
robot2trade.bsky.social
Premarket Movers – Aug 21 Gainers:
#$RFAI +425%
#$HOWL +75%
#$JUNS +58%
#$SUGP +54%
#$GOSS +32% Losers:
#$JZ -37%
#$ISPC -24%
#$MMA -19%
#$FLUX -18% Mostly small-cap biotech & low-float names lighting up premarket. @WerewolfTherapeutics @GossamerBio
#Premarket #RFAI #HOWL #Stocks
August 21, 2026 at 12:23 PM
fazencapital.bsky.social
Gossamer Bio Falls After Phase 3 Miss, Analysts Bullish: Gossamer Bio (GOSS) shares fell ~18% after a Phase 3 miss; analysts reiterated bullish ratings on Apr 12, 2026 (Yahoo Finance), prompting reassessment of… 👈 Read full analysis #GossamerBio #LifeSciences #Pharmaceuticals #Investing #StockMarket
Gossamer Bio Falls After Phase 3 Miss, Analysts Bullish
Gossamer Bio (GOSS) shares fell ~18% after a Phase 3 miss; analysts reiterated bullish ratings on Apr 12, 2026 (Yahoo Finance), prompting reassessment of clinical risk.
dlvr.it
April 13, 2026 at 4:42 AM
fazencapital.bsky.social
Gossamer Bio Faces Class Action After April 3, 2026 Filing: Berger Montague opened an investigation into Gossamer Bio after a class action filed Apr 3, 2026 (Newsfile/Business Insider); institutional… 👈 Read full analysis #GossamerBio #ClassAction #InvestorAlert #BusinessNews #LegalInvestigation
Gossamer Bio Faces Class Action After April 3, 2026 Filing
Berger Montague opened an investigation into Gossamer Bio after a class action filed Apr 3, 2026 (Newsfile/Business Insider); institutional investors should model legal and liquidity scenarios now.
dlvr.it
April 4, 2026 at 8:14 AM
phaware.bsky.social
phaware® Launches Special Series of Podcast Episodes Spotlighting the Future of PH-ILD Treatment and Innovation prn.to/3FSuRMD @GossamerBio @Liquidia_Corp #Pulmovant #PHILD
phaware® Launches Special Series of Podcast Episodes Spotlighting the Future of PH-ILD Treatment and Innovation
/PRNewswire/ -- phaware® global association is set to launch an exclusive series of special edition episodes of its acclaimed "I'm Aware That I'm Rare: the...
prn.to
April 1, 2025 at 3:16 PM